Springbok Capital Management »

Cerevel Therapeutics Hldng I shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.7M 135k 42.27

More positions owned by Springbok Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation (NVDA)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Brighthouse Finl (BHF)
Bio Rad Labs Cl A (BIO)
Baidu Spon Adr Rep A (BIDU)
Pioneer Natural Resources
Hess (HES)
Microsoft Corporation (MSFT)
Overstock (BYON)
Netease Sponsored Ads (NTES)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Springbok Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I